TITLE
Partially exhausted CD8+ T cells are associated with clinically beneficial response to Teplizumab in new onset type I diabetes

ORGANISM
Homo sapiens

SUMMARY
This SuperSeries is composed of the SubSeries listed below.

DESIGN
Refer to individual Series

PLATFORM
GPL10558 Illumina HumanHT-12 V4.0 expression beadchip GPL11154 Illumina HiSeq 2000 (Homo sapiens) GPL15456 Illumina HiScanSQ (Homo sapiens) GPL16791 Illumina HiSeq 2500 (Homo sapiens)

CITATIONS
Long SA, Thorpe J, DeBerg HA, Gersuk V, Eddy J, Harris KM, Ehlers M, Herold K, Nepom GT, Linsley PS. Partially exhausted CD8 T cells are associated with clinical response to teplizumab in new-onset type 1 diabetes. Science Immunology 2016 Nov 18. Vol. 1, Issue 5. DOI:10.1126/sciimmunol.aai7793

